Two adults with hypertriglyceridemia. How should one manage these persons
AbstractThe paper discusses the management of two individuals with asymptomatic hypertriglyceredemia, a common problem faces by Family Physicians in Malaysia. In such instances it is advisable to exclude an underlying disorder (e.g. metabolic syndrome) and take a pragmatic approach.
Ong HT. A man with dyslipidemia: to treat to not to treat? Malaysia Family Physician. 2006;1(1):40-1.
Grundy SM, Cleeman JI, Merz CNB, et al, for the Coordinating Committee of the National Cholesterol Education Program. NCEP Reort: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110(2):227-39.
ATP III Guidelines At-A-Glance Quick Desk Reference by the National Institute of Health. Accessed on 23 April 2008 from: http://www.nhlbi.nih.gov/guidelines/cholesterol/atglance.pdf.
D’Agostino RB, Ramachandran SV, Pensina MJ, at al. General cardiovascular risk profile for use in primary care - the Framingham Study. Circulation. 2008;117(6):743-53.
British National Formulary 2007. British Medical Association and Royal Pharmaceutical Society of Great Britain.
Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299-308.
Brunzell JD. Hypertriglyceridemia. N Engl J Med. 2007;357(10):1009-14.
Studer M, Briel M, Leimenstoll B, et al. Effect of different antilipidemic agents and diets on mortality: A systematic review. Arch Intern Med. 2005;165(7):725-30.
Cosat J, Borges M, Claudio D, Carneiro AV. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomized controlled trials. BMJ. 2006:332:1115-24.
Mark KH, Kark JD, Chia KS, et al. Ethnic differences in utilization of invasive cardiac procedures and in long-term survival following acute myocardial infarction. Clin Cardiol. 2004:27:275-280.